Supporting Families with Clarity and Compassion
At NeuroAI, we are profoundly committed to accurate, evidence-informed information, public health, and compassionate support for families. We recognize that recent media reports speculating about a possible connection between prenatal acetaminophen (Tylenol) use and autism may cause concern and uncertainty. It is essential that families know these discussions are complex and should be guided by trusted healthcare providers and specialists who are best equipped to interpret emerging research.
We strongly emphasize the critical importance of open and informed dialogue between families and healthcare professionals. Medical decisions should always be made in consultation with qualified clinicians. NeuroAI stands firmly with specialized institutions and experts who lead research and education in this area, including the Autism Alliance of Canada and the World Health Organization (WHO), whose work we deeply value and support.
Our collective priority must remain, ensuring that autistic people receive the support, respect, and inclusion they deserve as valued members of our communities. We encourage families to focus on supporting their child’s growth, recognizing their individuality, and creating opportunities for them to thrive — while relying on professional medical guidance for health-related questions.
Sources
Autism Alliance – Affirming Evidence, Dignity, and Inclusion in Autism Discourse
World Health Organization Statement
Society of Obstetricians and Gynaecologists of Canada (SOGC)
Other links
Statement on the use of acetaminophen (Tylenol) during pregnancy
What the research says about autism and acetaminophen use during pregnancy
Updated 9 November 2026: we changed how this post describes BRIDGES and NeuroAI, so it matches what BRIDGES does today.